세계의 의약품 시장 보고서(2025년)

A pharmaceutical drug is a substance designed for the treatment, prevention, or alleviation of an illness, condition, or its symptoms. These substances can be administered through various methods, including oral consumption, skin patches, injections, or inhalation. Notable pharmaceuticals derived from natural sources encompass vaccinations, steroid hormones, human blood-plasma fractions, and antibiotics.

The primary categories of pharmaceutical drugs cover a wide spectrum, including cardiovascular drugs, dermatology drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs, anti-infective drugs, metabolic disorders drugs, musculoskeletal disorders drugs, central nervous system drugs, oncology drugs, ophthalmology drugs, and respiratory diseases drugs. Cardiovascular drugs are specifically tailored to address medical conditions related to the heart or circulatory system, such as arrhythmias, blood clots, coronary artery disease, high or low blood pressure, high cholesterol, heart failure, and stroke. These drugs can be administered through various routes, including oral and parenteral methods, and are categorized as branded or generic drugs. The acquisition of pharmaceutical drugs can occur through prescription-based or over-the-counter channels, with distribution taking place through hospital pharmacies, retail pharmacies/drug stores, and other outlets.

The pharmaceutical drug market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical drug market statistics, including pharmaceutical drug industry global market size, regional shares, competitors with a pharmaceutical drug market share, detailed pharmaceutical drug market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical drug industry. This pharmaceutical drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical drugs market size has grown strongly in recent years. It will grow from $1747.07 billion in 2024 to $1864.73 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to rise in healthcare awareness, increased prevalence of respiratory diseases, changes in lifestyles, increase in pharmaceutical research and development (R&D) expenditure, increasing aging population, increased number of surgical procedures, strong economic growth in emerging markets and increased number of approvals for hematology/oncology (cancer) drugs.

The pharmaceutical drugs market size is expected to see strong growth in the next few years. It will grow to $2384.53 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing government support, increase in healthcare access, increase in investments, rapid growth in elderly population, rise in healthcare expenditure and rising awareness on immunization and vaccination. Major trends in the forecast period include use of biomarkers for drug development, increased development of next generation biologics, increased focus on personalized medicine, investment in artificial intelligence (AI) for drugs discovery, combination drug therapy to treat respiratory diseases, partnerships with wearables companies to improve drug research and development, use of 3D printing technology in drug manufacturing, microneedle pills to improve and enhance drug delivery and development of vaccines using MRNA.

The increase in sedentary jobs, busy lifestyles, and evolving consumer preferences is impacting the global disease landscape, particularly the prevalence of non-communicable diseases such as cancer, diabetes, and cardiovascular conditions. Factors such as prolonged working hours, reduced physical activity, and unhealthy dietary habits contribute significantly to chronic diseases such as diabetes. According to the World Health Organization, noncommunicable diseases (NCDs) account for 41 million deaths annually, representing 74% of global mortality. This trend underscores the growing demand for biologic drugs to address conditions such as diabetes. These factors are anticipated to expand the global patient population, thereby fostering growth in the pharmaceutical drug market throughout the forecast period.

The rising incidence of rare diseases is anticipated to drive growth in the pharmaceutical drug market in the future. A rare disease is characterized by its low prevalence, affecting only a small number of individuals compared to more common health issues. Pharmaceutical drugs play a crucial role in better managing these diseases, identifying potential therapeutics, and preventing unnecessary treatments that may have severe side effects, thus facilitating effective treatment. For example, in July 2023, the GOV.UK, a UK government department, reported that there are currently over 7,000 known rare diseases, with new ones continually being identified as research advances. Approximately 80% of these diseases have a recognized genetic basis, and it is estimated that 1 in 17 people will be affected by a rare disease at some point in their lives. Consequently, the increasing incidence of rare diseases is contributing to the growth of the pharmaceutical drug market.

Leading companies in the pharmaceutical drug market are introducing innovative medications such as Sohonos (palovarotene) capsules to establish a competitive advantage. Sohonos, a retinoid, is designed to reduce the volume of new heterotopic ossification in individuals with fibrodysplasia ossificans progressiva (FOP). For instance, in August 2023, Ipsen Biopharmaceuticals, Inc., a France-based biopharmaceutical company, unveiled Sohonos (palovarotene). This retinoid is indicated for minimizing the volume of new heterotopic ossification in adults and pediatric patients (8 years and older for females, 10 years and older for males) with FOP-a rare genetic disorder characterized by abnormal bone development in areas not typically containing bone, leading to limited movement, deformities, and severe disability.

Leading companies in the pharmaceutical drug market are launching innovative medications, such as generic cancer drugs, to enhance treatment affordability and accessibility. A generic cancer drug is defined as a medication that contains the same active ingredients, dosage, safety, strength, quality, and intended use as a brand-name cancer drug, but is usually offered at a lower price. For example, in August 2024, Lupin Limited, an India-based pharmaceutical company, introduced Doxorubicin Hydrochloride Liposome Injection in the United States. This product is a generic equivalent of Baxter Healthcare's Doxil, which is used for treating ovarian cancer, AIDS-related Kaposi's Sarcoma, and multiple myeloma. The medication is available in single-dose vials of 20 mg/10 mL and 50 mg/25 mL. This launch comes after receiving FDA approval through Lupin's alliance partner, ForDoz Pharma Corporation, and is part of Lupin's strategy to expand its oncology portfolio.

Major companies operating in the pharmaceutical drugs market include Pfizer Inc., AbbVie, Johnson & Johnson, Merck & Co, Sanofi S.A., F. Hoffmann-La Roche Ltd., Novartis AG, Bristol-Myers Squibb, AstraZeneca, GlaxosmithKline, Shanghai Pharmaceutical Drugs, Shanghai Fosun Pharmaceutical, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co., Ltd. (Sinopharm), Shanghai Acebright Pharmaceutical Drugs Group Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd, Hanmi Pharmaceutical, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharma, KYORIN Holdings, Inc., Nichi-Iko Pharmaceutical Co., Ltd., Daewoong Pharmaceutical Co.,Ltd, Kalbe Farma, Hyphens Pharma, Adjuvanz Technology Pte Ltd., Alliance Pharm Pte Ltd., Teva UK Limited, Abbott Laboratories, Vectura Group, Boehringer Ingelheim, Mylan, Zentiva, Apotex, Gilead Sciences, Bayer, Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV (Senosiain), Siegfried Rhein, Eli Lilly & Company, Biogen, EMS Pharma, Hypermarcas, Eurofarma, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, Uniao Quimica, Ache, Mantecorp Farmasa, Libbs, FQM Grupo, Spimaco, Jamjoom Pharma, Tabuk Pharmaceutical Manufacturing, Jazeera Pharmaceutical Industries, Julphar, Neopharma, Eurolab, Aspen Pharmacare Holdings Limited

North America was the largest region in the pharmaceutical drugs market in 2024. Middle East is expected to be the fargest growing region in the forecast period. The regions covered in the pharmaceutical drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical drugs market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The pharmaceutical drug market consists of sales of generic drugs, over-the-counter medications, bulk drugs, vaccines, biosimilars, and biologics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Others
• 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels
• 3) By Drug Classification: Branded Drugs, Generic Drugs
• 4) By Mode Of Purchase: Over-The-Counter (OTC) Drugs, Prescription-Based Drugs
• Subsegments:
• 1) By Cardiovascular Drugs: Antihypertensives; Anticoagulants; Cholesterol-lowering agents
• 2) By Dermatology Drugs: Topical Corticosteroids; Acne Treatments; Psoriasis Treatments
• 3) By Gastrointestinal Drugs: Antacids; Proton Pump Inhibitors; Laxatives
• 4) By Genito-Urinary Drugs: Hormonal Therapies; Anticholinergics for Overactive Bladder; Erectile Dysfunction Medications
• 5) By Hematology Drugs: Anticoagulants; Blood Volume Expanders; Erythropoiesis Stimulating Agents
• 6) By Anti-Infective Drugs: Antibiotics; Antivirals; Antifungals
• 7) By Metabolic Disorder Drugs: Diabetes Medications; Obesity Management Drugs; Thyroid Hormone Replacement
• 8) By Musculoskeletal Disorder Drugs: Non-steroidal Anti-inflammatory Drugs (NSAIDs); Disease-modifying Antirheumatic Drugs (DMARDs); Muscle Relaxants
• 9) By Central Nervous System Drugs: Antidepressants; Antipsychotics; Anxiolytics
• 10) By Others: Chemotherapeutics; Targeted Therapies; Immunotherapies; Glaucoma Treatments; Anti-allergy Drops; Retinal Disease Medications; Asthma Inhalers; COPD Medications; Antihistamines; Vaccines for Infectious Diseases; Therapeutic Nutrients for Chronic Conditions; Calcium Supplements; Iron Supplements; Magnesium Supplements
• Companies Mentioned: Pfizer Inc.; AbbVie; Johnson & Johnson; Merck & Co; Sanofi S.A.
• Countries: Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Drugs Market Characteristics

3. Pharmaceutical Drugs Market Trends And Strategies

4. Pharmaceutical Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pharmaceutical Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Drugs Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Drugs Total Addressable Market (TAM)

6. Pharmaceutical Drugs Market Segmentation

• 6.1. Global Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Drugs
• Dermatology Drugs
• Gastrointestinal Drugs
• Genito-Urinary Drugs
• Hematology Drugs
• Anti-Infective Drugs
• Metabolic Disorder Drugs
• Musculoskeletal Disorder Drugs
• Central Nervous System Drugs
• Others
• 6.2. Global Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies/ Drug Stores
• Other Distribution Channels
• 6.3. Global Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Branded Drugs
• Generic Drugs
• 6.4. Global Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Over-The-Counter (OTC) Drugs
• Prescription-Based Drugs
• 6.5. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Cardiovascular Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihypertensives
• Anticoagulants
• Cholesterol-lowering Agents
• 6.6. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Dermatology Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Corticosteroids
• Acne Treatments
• Psoriasis Treatments
• 6.7. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Gastrointestinal Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antacids
• Proton Pump Inhibitors
• Laxatives
• 6.8. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Genito-Urinary Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hormonal Therapies
• Anticholinergics for Overactive Bladder
• Erectile Dysfunction Medications
• 6.9. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Hematology Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anticoagulants
• Blood Volume Expanders
• Erythropoiesis Stimulating Agents
• 6.10. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Anti-Infective Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Antivirals
• Antifungals
• 6.11. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Metabolic Disorder Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diabetes Medications
• Obesity Management Drugs
• Thyroid Hormone Replacement
• 6.12. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Musculoskeletal Disorder Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-steroidal Anti-inflammatory Drugs (NSAIDs)
• Disease-modifying Antirheumatic Drugs (DMARDs)
• Muscle Relaxants
• 6.13. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Central Nervous System Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antidepressants
• Antipsychotics
• Anxiolytics
• 6.14. Global Pharmaceutical Drugs Market, Sub-Segmentation Of Others, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapeutics
• Targeted Therapies
• Immunotherapies
• Glaucoma Treatments
• Anti-allergy Drops
• Retinal Disease Medications
• Asthma Inhalers
• COPD Medications
• Antihistamines
• Vaccines for Infectious Diseases
• Therapeutic Nutrients for Chronic Conditions
• Calcium Supplements
• Iron Supplements
• Magnesium Supplements

7. Pharmaceutical Drugs Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Drugs Market

• 8.1. Asia-Pacific Pharmaceutical Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Drugs Market

• 9.1. China Pharmaceutical Drugs Market Overview
• 9.2. China Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Drugs Market

• 10.1. India Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Drugs Market

• 11.1. Japan Pharmaceutical Drugs Market Overview
• 11.2. Japan Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Drugs Market

• 12.1. Australia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Drugs Market

• 13.1. Indonesia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Drugs Market

• 14.1. South Korea Pharmaceutical Drugs Market Overview
• 14.2. South Korea Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Bangladesh Pharmaceutical Drugs Market

• 15.1. Bangladesh Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Bangladesh Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Bangladesh Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. Thailand Pharmaceutical Drugs Market

• 16.1. Thailand Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. Thailand Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. Thailand Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Vietnam Pharmaceutical Drugs Market

• 17.1. Vietnam Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Vietnam Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Vietnam Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. Malaysia Pharmaceutical Drugs Market

• 18.1. Malaysia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. Malaysia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. Malaysia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Singapore Pharmaceutical Drugs Market

• 19.1. Singapore Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Singapore Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Singapore Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Philippines Pharmaceutical Drugs Market

• 20.1. Philippines Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Philippines Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Philippines Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Hong Kong Pharmaceutical Drugs Market

• 21.1. Hong Kong Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.2. Hong Kong Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Hong Kong Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. New Zealand Pharmaceutical Drugs Market

• 22.1. New Zealand Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. New Zealand Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. New Zealand Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. Western Europe Pharmaceutical Drugs Market

• 23.1. Western Europe Pharmaceutical Drugs Market Overview
• 23.2. Western Europe Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. Western Europe Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. Western Europe Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. UK Pharmaceutical Drugs Market

• 24.1. UK Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.2. UK Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. UK Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Germany Pharmaceutical Drugs Market

• 25.1. Germany Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.2. Germany Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Germany Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. France Pharmaceutical Drugs Market

• 26.1. France Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.2. France Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. France Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Italy Pharmaceutical Drugs Market

• 27.1. Italy Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Italy Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Italy Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Spain Pharmaceutical Drugs Market

• 28.1. Spain Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.2. Spain Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Spain Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Spain Pharmaceutical Drugs Market

• 29.1. Spain Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.2. Spain Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Spain Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Austria Pharmaceutical Drugs Market

• 30.1. Austria Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 30.2. Austria Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 30.3. Austria Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

31. Belgium Pharmaceutical Drugs Market

• 31.1. Belgium Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 31.2. Belgium Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 31.3. Belgium Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

32. Denmark Pharmaceutical Drugs Market

• 32.1. Denmark Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 32.2. Denmark Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 32.3. Denmark Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

33. Finland Pharmaceutical Drugs Market

• 33.1. Finland Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 33.2. Finland Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 33.3. Finland Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

34. Ireland Pharmaceutical Drugs Market

• 34.1. Ireland Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 34.2. Ireland Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 34.3. Ireland Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

35. Netherlands Pharmaceutical Drugs Market

• 35.1. Netherlands Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 35.2. Netherlands Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 35.3. Netherlands Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

36. Norway Pharmaceutical Drugs Market

• 36.1. Norway Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 36.2. Norway Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 36.3. Norway Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

37. Portugal Pharmaceutical Drugs Market

• 37.1. Portugal Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 37.2. Portugal Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 37.3. Portugal Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

38. Sweden Pharmaceutical Drugs Market

• 38.1. Sweden Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 38.2. Sweden Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 38.3. Sweden Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

39. Switzerland Pharmaceutical Drugs Market

• 39.1. Switzerland Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 39.2. Switzerland Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 39.3. Switzerland Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

40. Eastern Europe Pharmaceutical Drugs Market

• 40.1. Eastern Europe Pharmaceutical Drugs Market Overview
• 40.2. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 40.3. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 40.4. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

41. Russia Pharmaceutical Drugs Market

• 41.1. Russia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 41.2. Russia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 41.3. Russia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

42. Czech Republic Pharmaceutical Drugs Market

• 42.1. Czech Republic Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 42.2. Czech Republic Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 42.3. Czech Republic Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

43. Poland Pharmaceutical Drugs Market

• 43.1. Poland Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 43.2. Poland Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 43.3. Poland Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

44. Romania Pharmaceutical Drugs Market

• 44.1. Romania Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 44.2. Romania Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 44.3. Romania Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

45. Ukraine Pharmaceutical Drugs Market

• 45.1. Ukraine Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 45.2. Ukraine Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 45.3. Ukraine Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

46. North America Pharmaceutical Drugs Market

• 46.1. North America Pharmaceutical Drugs Market Overview
• 46.2. North America Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 46.3. North America Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 46.4. North America Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

47. USA Pharmaceutical Drugs Market

• 47.1. USA Pharmaceutical Drugs Market Overview
• 47.2. USA Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 47.3. USA Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 47.4. USA Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

48. Canada Pharmaceutical Drugs Market

• 48.1. Canada Pharmaceutical Drugs Market Overview
• 48.2. Canada Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 48.3. Canada Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 48.4. Canada Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 49.1. Mexico Pharmaceutical Drugs Market Overview
• 49.2. Mexico Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 49.3. Mexico Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 49.4. Mexico Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

50. South America Pharmaceutical Drugs Market

• 50.1. South America Pharmaceutical Drugs Market Overview
• 50.2. South America Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 50.3. South America Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 50.4. South America Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

51. Brazil Pharmaceutical Drugs Market

• 51.1. Brazil Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 51.2. Brazil Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 51.3. Brazil Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

52. Chile Pharmaceutical Drugs Market

• 52.1. Chile Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 52.2. Chile Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 52.3. Chile Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

53. Argentina Pharmaceutical Drugs Market

• 53.1. Argentina Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 53.2. Argentina Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 53.3. Argentina Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

54. Colombia Pharmaceutical Drugs Market

• 54.1. Colombia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 54.2. Colombia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 54.3. Colombia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

55. Peru Pharmaceutical Drugs Market

• 55.1. Peru Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 55.2. Peru Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 55.3. Peru Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

56. Middle East Pharmaceutical Drugs Market

• 56.1. Middle East Pharmaceutical Drugs Market Overview
• 56.2. Middle East Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 56.3. Middle East Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 56.4. Middle East Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

57. Saudi Arabia Pharmaceutical Drugs Market

• 57.1. Saudi Arabia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 57.2. Saudi Arabia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 57.3. Saudi Arabia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

58. Israel Pharmaceutical Drugs Market

• 58.1. Israel Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 58.2. Israel Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 58.3. Israel Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

59. Iran Pharmaceutical Drugs Market

• 59.1. Iran Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 59.2. Iran Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 59.3. Iran Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

60. Turkey Pharmaceutical Drugs Market

• 60.1. Turkey Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 60.2. Turkey Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 60.3. Turkey Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

61. United Arab Emirates Pharmaceutical Drugs Market

• 61.1. United Arab Emirates Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 61.2. United Arab Emirates Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 61.3. United Arab Emirates Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

62. Africa Pharmaceutical Drugs Market

• 62.1. Africa Pharmaceutical Drugs Market Overview
• 62.2. Africa Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 62.3. Africa Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 62.4. Africa Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

63. Egypt Pharmaceutical Drugs Market

• 63.1. Egypt Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 63.2. Egypt Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 63.3. Egypt Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

64. Nigeria Pharmaceutical Drugs Market

• 64.1. Nigeria Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 64.2. Nigeria Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 64.3. Nigeria Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

65. South Africa Pharmaceutical Drugs Market

• 65.1. South Africa Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 65.2. South Africa Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 65.3. South Africa Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

66. Pharmaceutical Drugs Market Competitive Landscape And Company Profiles

• 66.1. Pharmaceutical Drugs Market Competitive Landscape
• 66.2. Pharmaceutical Drugs Market Company Profiles
  • 66.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 66.2.2. AbbVie Overview, Products and Services, Strategy and Financial Analysis
  • 66.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 66.2.4. Merck & Co Overview, Products and Services, Strategy and Financial Analysis
  • 66.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

67. Pharmaceutical Drugs Market Other Major And Innovative Companies

• 67.1. F. Hoffmann-La Roche Ltd.
• 67.2. Novartis AG
• 67.3. Bristol-Myers Squibb
• 67.4. AstraZeneca
• 67.5. GlaxosmithKline
• 67.6. Shanghai Pharmaceutical Drugs
• 67.7. Shanghai Fosun Pharmaceutical
• 67.8. Takeda Pharmaceutical Company Ltd.
• 67.9. Otsuka Pharmaceutical Co. Ltd.
• 67.10. Daiichi Sankyo
• 67.11. China National Pharmaceutical Group Co., Ltd. (Sinopharm)
• 67.12. Shanghai Acebright Pharmaceutical Drugs Group Co., Ltd.
• 67.13. Jiangsu Hengrui Medicine Co., Ltd
• 67.14. Hanmi Pharmaceutical
• 67.15. Cipla Limited

68. Global Pharmaceutical Drugs Market Competitive Benchmarking And Dashboard

69. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market

70. Recent Developments In The Pharmaceutical Drugs Market

71. Pharmaceutical Drugs Market High Potential Countries, Segments and Strategies

• 71.1 Pharmaceutical Drugs Market In 2029 - Countries Offering Most New Opportunities
• 71.2 Pharmaceutical Drugs Market In 2029 - Segments Offering Most New Opportunities
• 71.3 Pharmaceutical Drugs Market In 2029 - Growth Strategies
  • 71.3.1 Market Trend Based Strategies
  • 71.3.2 Competitor Strategies

72. Appendix

• 72.1. Abbreviations
• 72.2. Currencies
• 72.3. Historic And Forecast Inflation Rates
• 72.4. Research Inquiries
• 72.5. The Business Research Company
• 72.6. Copyright And Disclaimer